Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brachytherapy | 12 | 2016 | 1005 | 1.670 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 16 | 2016 | 2458 | 1.240 |
Why?
|
| Monte Carlo Method | 11 | 2009 | 708 | 1.150 |
Why?
|
| Radiometry | 8 | 2014 | 1020 | 0.990 |
Why?
|
| Uterine Cervical Neoplasms | 7 | 2018 | 1903 | 0.570 |
Why?
|
| Algorithms | 5 | 2016 | 3906 | 0.560 |
Why?
|
| Radiation Protection | 3 | 2009 | 204 | 0.530 |
Why?
|
| Skin Physiological Phenomena | 1 | 2012 | 40 | 0.410 |
Why?
|
| Models, Statistical | 3 | 2016 | 1186 | 0.400 |
Why?
|
| Iridium Radioisotopes | 3 | 2009 | 57 | 0.390 |
Why?
|
| Models, Biological | 3 | 2012 | 3186 | 0.380 |
Why?
|
| Radiotherapy Dosage | 11 | 2014 | 4020 | 0.350 |
Why?
|
| Catheterization, Peripheral | 1 | 2010 | 153 | 0.310 |
Why?
|
| Radiation Dosage | 2 | 2012 | 1042 | 0.310 |
Why?
|
| Computer Simulation | 6 | 2016 | 1568 | 0.280 |
Why?
|
| Radiotherapy, Conformal | 1 | 2012 | 898 | 0.280 |
Why?
|
| Sensitivity and Specificity | 6 | 2016 | 5157 | 0.280 |
Why?
|
| Radiation Injuries | 3 | 2018 | 1476 | 0.270 |
Why?
|
| Reproducibility of Results | 6 | 2016 | 6193 | 0.250 |
Why?
|
| Rectum | 3 | 2009 | 480 | 0.250 |
Why?
|
| Urinary Bladder | 3 | 2009 | 592 | 0.240 |
Why?
|
| Mammaplasty | 1 | 2010 | 714 | 0.220 |
Why?
|
| Phantoms, Imaging | 6 | 2014 | 1330 | 0.190 |
Why?
|
| Scattering, Radiation | 3 | 2016 | 334 | 0.180 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 16242 | 0.180 |
Why?
|
| Photons | 3 | 2008 | 536 | 0.180 |
Why?
|
| Equipment Design | 5 | 2010 | 1207 | 0.160 |
Why?
|
| Software | 1 | 2006 | 1357 | 0.160 |
Why?
|
| Genital Neoplasms, Female | 1 | 2005 | 794 | 0.150 |
Why?
|
| Finite Element Analysis | 2 | 2008 | 55 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2014 | 7787 | 0.110 |
Why?
|
| Organs at Risk | 1 | 2016 | 559 | 0.100 |
Why?
|
| Film Dosimetry | 3 | 2009 | 62 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2018 | 1858 | 0.090 |
Why?
|
| Organ Specificity | 1 | 2012 | 734 | 0.090 |
Why?
|
| Cesium Radioisotopes | 1 | 2009 | 38 | 0.090 |
Why?
|
| Body Burden | 2 | 2006 | 64 | 0.080 |
Why?
|
| Endometrial Neoplasms | 1 | 2018 | 1385 | 0.080 |
Why?
|
| Relative Biological Effectiveness | 2 | 2006 | 227 | 0.080 |
Why?
|
| Humans | 19 | 2018 | 270602 | 0.070 |
Why?
|
| Equipment Failure Analysis | 2 | 2006 | 324 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2006 | 751 | 0.070 |
Why?
|
| Female | 11 | 2018 | 148790 | 0.070 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2018 | 2178 | 0.070 |
Why?
|
| Time Factors | 3 | 2009 | 12971 | 0.070 |
Why?
|
| Software Validation | 1 | 2006 | 30 | 0.070 |
Why?
|
| Benchmarking | 1 | 2008 | 275 | 0.070 |
Why?
|
| Gels | 1 | 2005 | 106 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2006 | 206 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 906 | 0.060 |
Why?
|
| Nanoparticles | 1 | 2009 | 584 | 0.060 |
Why?
|
| Prostatic Neoplasms | 2 | 2013 | 5869 | 0.060 |
Why?
|
| Polymers | 1 | 2005 | 223 | 0.060 |
Why?
|
| Proton Therapy | 1 | 2013 | 1637 | 0.050 |
Why?
|
| Models, Theoretical | 2 | 2009 | 799 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2016 | 33811 | 0.050 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2002 | 303 | 0.040 |
Why?
|
| Water | 1 | 2002 | 386 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2005 | 2856 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 1691 | 0.040 |
Why?
|
| Pelvis | 1 | 2018 | 381 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2014 | 2360 | 0.030 |
Why?
|
| Synchrotrons | 1 | 2013 | 35 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2008 | 4148 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 879 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2005 | 13413 | 0.020 |
Why?
|
| Tungsten | 1 | 2009 | 17 | 0.020 |
Why?
|
| Alloys | 1 | 2009 | 29 | 0.020 |
Why?
|
| Rotation | 1 | 2009 | 98 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2013 | 593 | 0.020 |
Why?
|
| Prostate | 1 | 2013 | 1090 | 0.020 |
Why?
|
| Uncertainty | 1 | 2009 | 327 | 0.020 |
Why?
|
| Polystyrenes | 1 | 2005 | 36 | 0.020 |
Why?
|
| X-Ray Film | 1 | 2005 | 31 | 0.020 |
Why?
|
| Particle Accelerators | 1 | 2008 | 362 | 0.020 |
Why?
|
| Electrons | 1 | 2006 | 188 | 0.020 |
Why?
|
| Calibration | 1 | 2005 | 346 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 534 | 0.010 |
Why?
|
| Radiography | 1 | 2008 | 1993 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 90450 | 0.010 |
Why?
|
| Neoplasms | 1 | 2006 | 15931 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2002 | 12038 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 7912 | 0.010 |
Why?
|
| Male | 2 | 2013 | 128395 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2007 | 39922 | 0.000 |
Why?
|